SCOPUS 정보 검색 플랫폼

Journal of Steroid Biochemistry and Molecular Biology

Volumn 103, Issue 3-5, 2007, Pages 717-720

Evaluation of C-2-substituted 19-nor-1α,25-dihydroxyvitamin D3 analogs as therapeutic agents for prostate cancer

(9) Chen, T C a Persons, K S a Zheng, S a Mathieu, J a Holick, M F a Lee, Y F b Bao, B b Arai, M A c Kittaka, A c

a BOSTON UNIVERSITY SCHOOL OF MEDICINE (United States)

b UNIVERSITY OF ROCHESTER (United States)

c TEIKYO UNIVERSITY (Japan)

Author keywords

Analog; Invasion; PC 3; Proliferation; Prostate cancer; PZ HPV 7; Vitamin D

Indexed keywords

19 NOR 2ALPHA (3 HYDROXYLPROPYL) 1ALPHA,25 DIHYDROXYVITAMIN D 3; 19 NOR 2BETA (3 HYDROXYLPROPYL) 1ALPHA,25 DIHYDROXYVITAMIN D 3; CALCITRIOL; COLECALCIFEROL DERIVATIVE; THYMIDINE; TRITIUM; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL COUNT; CELL INVASION; CONTROLLED STUDY; DRUG POTENCY; HUMAN; HUMAN CELL; MALE; MITOSIS INHIBITION; PROSTATE CANCER;

CALCITRIOL; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; MALE; PROSTATIC NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 33947187323 PISSN: 09600760 EISSN: None Source Type: Journal
DOI: 10.1016/j.jsbmb.2006.12.009 Document Type: Article

Times cited : (33)

References (11)

1
- 33645526144
- Cancer Statistics, 2006
- Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., and Thun J.M. Cancer Statistics, 2006. CA Cancer J. Clin. 56 (2006) 106-130
- (2006) CA Cancer J. Clin. , vol.56 , pp. 106-130
- Jemal, A.¹ Siegel, R.² Ward, E.³ Murray, T.⁴ Xu, J.⁵ Smigal, C.⁶ Thun, J.M.⁷

2
- 0001013226
- 3 (calcitriol) in hormone refractory prostate cancer
- 3 (calcitriol) in hormone refractory prostate cancer. Urol. Oncol. 1 (1995) 195-198
- (1995) Urol. Oncol. , vol.1 , pp. 195-198
- Osborn, J.L.¹ Schwartz, G.G.² Bahnson, R.³ Smith, D.C.⁴ Trump, D.L.⁵

3
- 0032439651
- 3 (calcitriol)
- 3 (calcitriol). J. Urol. 159 (1998) 2035-2040
- (1998) J. Urol. , vol.159 , pp. 2035-2040
- Gross, C.¹ Stamey, T.² Hancock, S.³ Feldman, D.⁴

4
- 0035035190
- Cancer chemoprevention using natural vitamin D and synthetic analogs
- Guyton K.Z., Kensler T.W., and Posner G.H. Cancer chemoprevention using natural vitamin D and synthetic analogs. Annu. Rev. Pharmacol. Toxicol. 41 (2001) 421-442
- (2001) Annu. Rev. Pharmacol. Toxicol. , vol.41 , pp. 421-442
- Guyton, K.Z.¹ Kensler, T.W.² Posner, G.H.³

5
- 0025228936
- 3. A novel vitamin D D-related compound with potential therapeutic activity
- 3. A novel vitamin D D-related compound with potential therapeutic activity. Tetrahedron Lett. 31 (1990) 1823-1824
- (1990) Tetrahedron Lett. , vol.31 , pp. 1823-1824
- Perman, K.L.¹ Sicinski, R.R.² Schnoes, H.K.³ DeLuca, H.F.⁴

6
- 0031794715
- 2
- 2. Am. J. Kidney Dis. 32 Suppl. 2 (1998) S48-S54
- (1998) Am. J. Kidney Dis. , vol.32 , Issue.SUPPL. 2
- Llach, F.¹ Keshav, G.² Goldblat, M.V.³ Lindberg, J.S.⁴ Sadler, R.⁵ Delmex, J.⁶ Arruda, J.⁷ Lau, A.⁸ Slatolpolsky, E.⁹

7
- 0034061507
- 2 for prostate cancer therapy
- 2 for prostate cancer therapy. Clin. Cancer Res. 6 (2000) 901-908
- (2000) Clin. Cancer Res. , vol.6 , pp. 901-908
- Chen, T.C.¹ Schwartz, G.G.² Burnstein, K.L.³ Lokeshwar, B.L.⁴ Holick, M.F.⁵

8
- 0036682003
- 3: synthesis, conformational analysis, biological activities, and docking to the modeled rVDR ligand binding domain
- 3: synthesis, conformational analysis, biological activities, and docking to the modeled rVDR ligand binding domain. J. Med. Chem. 45 (2002) 3366-3380
- (2002) J. Med. Chem. , vol.45 , pp. 3366-3380
- Sicinski, R.R.¹ Rotkiewics, P.² Kolinski, A.³ Sicinska, W.⁴ Prahl, J.M.⁵ Smith, C.M.⁶ DeLuca, H.F.⁷

9
- 10744233576
- 3 with Julia Olefination: high potency in induction of differentiation on HL-60 cells
- 3 with Julia Olefination: high potency in induction of differentiation on HL-60 cells. J. Org. Chem. 68 (2003) 7407-7415
- (2003) J. Org. Chem. , vol.68 , pp. 7407-7415
- Ono, K.¹ Yoshida, A.² Saito, N.³ Fujishima, T.⁴ Honzawa, S.⁵ Suhara, Y.⁶ Kishimoto, S.⁷ Sugiura, T.⁸ Waku, K.⁹ Takayama, H.¹⁰ Kittaka, A.¹¹

10
- 0028878369
- 3 are potentiated by epidermal growth factor and attenuated by insulin in cultured human keratinocytes
- 3 are potentiated by epidermal growth factor and attenuated by insulin in cultured human keratinocytes. J. Investig. Dermatol. 104 (1995) 113-117
- (1995) J. Investig. Dermatol. , vol.104 , pp. 113-117
- Chen, T.C.¹ Persons, K.² Liu, W.-W.³ Chen, M.L.⁴ Holick, M.F.⁵

11
- 29744463149
- 3 inhibits prostate cancer cell invasion via modulation of selective proteases
- 3 inhibits prostate cancer cell invasion via modulation of selective proteases. Carcinogenesis 27 (2006) 32-42
- (2006) Carcinogenesis , vol.27 , pp. 32-42
- Bao, B.Y.¹ Yeh, S.D.² Lee, Y.F.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.